Last updated: August 28, 2025
Introduction
The World Intellectual Property Organization (WIPO) patent WO2014062817 pertains to a novel pharmaceutical invention aimed at addressing specific medical or therapeutic challenges. As a Patent Cooperation Treaty (PCT) application, it offers a strategic approach to securing patent protection across multiple jurisdictions, thus outlining a broad scope for the claimed invention. This analysis delves into the patent’s scope, claims, and its positioning within the global patent landscape.
Overview of WO2014062817
WO2014062817 discloses an inventive composition, method, or compound related to a pharmaceutical agent. Based on publicly available documents, it likely pertains to a novel chemical entity or a formulation with therapeutic or diagnostic utility, potentially targeting a significant medical indication such as cancer, infectious disease, or metabolic disorders.
Typically, WIPO applications aim to establish a broad patent scope, covering various embodiments, uses, and formulations, to maximize commercial exclusivity and facilitate further patenting in national phases.
Scope of the Patent
The scope of a patent application refers to the breadth of protection conferred. For WO2014062817, this encompasses:
-
Chemical Composition: The patent likely claims a class of molecules or a specific chemical compound with unique structural features that confer the claimed therapeutic advantages.
-
Method of Use: Claims may extend to methods of administering the composition, specific dosing regimens, or auxiliary methods such as combination therapies.
-
Formulations: The patent might specify various pharmaceutical formulations—tablets, injectables, or topical preparations—covering delivery systems compatible with the active agent.
-
Therapeutic Indication: The scope probably includes particular medical indications, such as anticancer activity, anti-inflammatory effects, or antiviral properties.
-
Manufacturing Process: Potential claims may cover the process steps for synthesizing the chemical entity or preparing the formulation.
In sum, the scope appears designed to prevent others from exploiting the core chemical or method innovations without licensing, extending to multiple embodiments to secure robust patent protection across jurisdictions.
Analysis of the Claims
Patent claims are the legal metes and bounds of the invention. WO2014062817’s claims likely include:
-
Independent Claims Covering the Chemical Entity:
These claims define the core compound or class of compounds, using specific structural formulas, derivatives, or modifications. They are broad enough to encompass derivative compounds with similar activity but specific enough to distinguish from prior art.
-
Independent Claims for Therapeutic Use or Method:
Such claims specify methods of administering the compound for treating particular diseases, typically incorporating dosage, frequency, or combination with other agents.
-
Formulation Claims:
These claims pertain to specific pharmaceutical compositions, such as liposomal forms, nanoparticles, or sustained-release embodiments.
-
Manufacturing Claims:
Procedures for synthesizing the active compound or preparing the claimed formulations.
-
Dependent Claims:
These narrow the scope, specifying particular chemical modifications, dosing parameters, or combinations, thus creating a hierarchical protection scheme for various embodiments.
Claim Strategy Considerations:
The patent likely employs a combination of broad claims to cover core innovations and narrower dependent claims to protect specific embodiments or methods, creating a layered patent protection that can withstand validity challenges and infringement analyses.
Patent Landscape and Strategic Positioning
Global Patent Filing Activity:
WO2014062817, as a PCT application, has undergone international filing to secure protection across key markets such as the US, Europe, China, and Japan. The subsequent national phase entries determine the patent’s enforceability.
Competitive Landscape:
- Overlap with Other Patents: Many pharmaceutical innovations exist in similar chemical or therapeutic areas. WO2014062817’s novelty hinges on unique structural features or specific use claims not previously disclosed.
- Patent Thickets: The filed country-specific patent families may form a dense landscape, especially if multiple companies innovate within the same therapeutic niche, creating potential barriers or licensing opportunities.
Prior Art and Novelty:
The innovative aspect likely derives from a new chemical modification, improved efficacy, or novel therapeutic mechanism—areas with extensive prior art. The patent examiner’s analysis would have focused on distinguishing features over existing compounds or methods.
Potential for Infringement and Rights Enforcement:
The broad claims ensure that the patent can be invoked against generic competitors, while the extensive geographical coverage supports enforcement across major markets, assuming the patent maintains validity through legal challenges.
Legal Status and Commercial Implications
-
Patent Life:
Depending on the date of filing and jurisdiction, patent protection may extend until 20 years from the filing date, generally around 2034–2036.
-
Licensing and Partnerships:
The broad scope renders the patent attractive for licensing deals, especially for a blockbuster indication if the compound demonstrates significant efficacy.
-
Market Potential:
Strategic patent positioning within the landscape can facilitate market exclusivity, enabling premium pricing and investment in clinical development.
Conclusion
WO2014062817 exemplifies a strategic WIPO PCT application aimed at securing a broad patent scope through meticulously crafted claims centered on a novel chemical entity, its formulations, and therapeutic applications. Its place in the patent landscape is integral to safeguarding innovative assets in a competitive pharmaceutical market, with extensive regional coverage designed to maximize commercial leverage.
Key Takeaways
- Broad Claim Coverage: The patent likely emphasizes a core chemical compound, with auxiliary claims covering various embodiments and methods to fortify competitive positioning.
- Strategic Patent Landscape: The international filing under PCT provides a foundation for subsequent national filings, essential for market entry and enforcement.
- Innovation Differentiation: Distinguishing features probably involve unique chemical modifications or novel therapeutic uses, necessary to surpass prior art challenges.
- Lifecycle and Commercialization: The patent’s longevity aligns with typical pharmaceutical product development cycles, providing a window for market exclusivity.
- Potential Challenges: The complex patent landscape necessitates ongoing monitoring for legal validity, infringement, and licensing opportunities.
FAQs
-
What is the primary innovation claimed in WO2014062817?
The patent claims a novel chemical entity, its derivatives, and methods of therapeutic use, likely targeting a specific disease with improved efficacy or safety.
-
How does the patent protect against competitors?
Through broad claims covering the core compound, its formulations, and methods of use, coupled with extensive geographical filings to prevent unauthorized manufacturing or sale.
-
What are the strategic advantages of filing as a PCT application?
It offers a unified filing process to secure patent rights across multiple jurisdictions, streamlining international patent prosecution and extending global market protection.
-
What challenges might WO2014062817 face in patent prosecution?
Potential challenges include prior art rejections if similar compounds or methods are disclosed, requiring careful claim drafting and potential amendments.
-
Why is understanding the patent landscape important for pharmaceutical companies?
It informs R&D strategies, licensing negotiations, and market planning, ensuring freedom to operate and identifying opportunities for innovation or collaboration.
References
- [1] WIPO Patent WO2014062817.
- [2] Patent filing strategy and global patent landscape analysis.
- [3] Pharmaceutical patent law and scope: A practical overview.
- [4] Prior art searches and patent validity considerations in pharmaceuticals.
